NIH Grants and Funding Opportunities
Browse open NIH grants, research funding, and fellowships, with guidance on mechanisms like R01, R21, and R03 and how to pick the right one.
NIH funding is a system with its own vocabulary, and learning it is the fastest way to stop wasting cycles. Awards are organized by mechanism: R-series research grants (the flagship R01 for mature projects, R21 for exploratory ideas, R03 for small studies), K-series career development awards, F-series fellowships for trainees, and small-business programs. Each mechanism carries fixed expectations about preliminary data, project scope, duration, and career stage, so choosing the mechanism is really choosing the standard your application will be judged against.
The second structural fact is that the NIH is not one funder but a collection of institutes and centers, each with its own scientific priorities and paylines. The same proposal can be a strong fit at one institute and unfundable at another. Before writing, identify which institute’s mission covers your question, and consider contacting the relevant program officer, who can tell you whether the fit is real. That conversation is normal and expected, not an imposition.
Timing is rigid. Standard due dates recur in cycles, review takes months, and resubmission after a first rejection is a routine part of the process rather than a failure signal. Read the summary statement carefully, address the critiques, and come back stronger. Early-stage investigators should also check whether special payline considerations or career-stage programs apply to them.
Common mistakes include aiming an R01-sized idea at an R21, ignoring the specific funding opportunity announcement in favor of generic advice, and missing institutional deadlines that precede the NIH deadline. Use the live listings below to find open NIH opportunities, then read the full announcement on the official NIH site and confirm mechanism, institute fit, and due dates before drafting.
Current matching opportunities
These listings are limited to open, rolling, or upcoming opportunities that match this guide. Check the official source before applying.
2026 NIDA $100,000 Start an SUD Startup Challenge: Six-Month Mentorship and Startup Prizes
The NIDA challenge supports teams turning research ideas in drug use, misuse, or substance use disorder into potential U.S.-based startups through six-month mentorship and up to $100,000 in total cash prizes.
NIH NOURISH Autoimmunity Digital Health Challenge 2026–2028: Up to $650,000 in Prizes for Nutrition and Symptom-Tracking Tools
The NIH NOURISH challenge seeks digital health prototypes that help people with or at risk of autoimmune disease track nutrition alongside symptoms, with up to $650,000 in prizes across three development phases.
2027 NIA Start-Up Challenge and Accelerator: Up to $994,000 in Aging-Technology Prizes
The National Institute on Aging's 2027 Start-Up Challenge offers early-stage aging-technology innovators up to $994,000 in total cash prizes, a five-month accelerator, mentorship, and commercialization support, with submissions due January 15, 2027.
Exploratory/Developmental Grant (R21) | NIH
NIH R21 guide for exploratory, high-risk projects, with current parent-announcement tracks, budget rules, the next standard due date, and application planning.
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed): FY 2027 Shared Biomedical Instrument Grant
NIH's Seed Instrumentation Support (SIS) Program funds one new shared commercially available biomedical research instrument for an eligible US institution, with awards from $50,000 to $400,000 and the first current-cycle receipt date on September 25, 2026.
RFA-NS-27-015: BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
NIH's BRAIN Initiative NOFO supports U01 cooperative agreement projects that build scalable technologies for brain-wide connectivity mapping, with an estimated $10M commitment in the first year and approximately 3–6 awards expected.
RFA-MH-26-170: BRAIN Initiative - Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01)
NIH BRAIN Initiative reissue NOFO for R01 projects that develop and validate high-impact tools for precise, cell- and circuit-specific neuroscience research without clinical trials.
RFA-HL-27-004: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
NIH’s NHLBI RFA-HL-27-004 is a limited-competition R03 small grant opportunity to help current and recently completed NHLBI K01/K08/K23/K25 awardees advance toward independent funding through a short, NIH-funded pilot- to proof-of-concept scale project.
RFA-HL-26-019: Catalyze Product Definition - Medical Device Prototype Design/Testing and Disease Target Identification and Assay Development (R61/R33; Clinical Trial Not Allowed)
NIH NHLBI Catalyze Product Definition NOFO for early-stage device, diagnostic, and research-tool development in heart, lung, blood, and sleep diseases. The next new-application due date is October 21, 2026.
RFA-HL-26-018: Catalyze Product Definition for Small Molecules, Biologics, and Combination Products
An NIH R33 Catalyze Product Definition NOFO for early translational work that identifies a lead compound series and tests a combination-product prototype for heart, lung, blood, and sleep diseases. The next announced application date is October 21, 2026.
RFA-HL-26-016: Catalyze Enabling Technologies and Transformative Platforms for HLBS Research (R33)
The National Heart, Lung, and Blood Institute's Catalyze R33 supports further development and rigorous validation of transformative, multi-use technologies and platforms relevant to heart, lung, blood, and sleep research. The next listed application due date is 2026-10-21.
RFA-HL-26-002: NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
The NHLBI Outstanding Investigator Award provides up to 7 years of flexible R35 support, with applications requesting up to $700,000 in direct costs per year, for established investigators whose programs advance heart, lung, blood, and sleep research.
Application guidance
Use the listings above as a shortlist, then build your application from the official instructions. Save the source page, deadline, eligibility rules, required documents, contact details, and any program-specific scoring criteria. If the deadline is rolling, apply early enough for review queues and budget limits. If the deadline is fixed, work backward from the closing date and leave time for recommendations, institutional approvals, financial documents, and portal errors.
Popular funding types
NIH Grants and Funding Opportunities FAQ
What do the NIH mechanism codes like R01 and R21 mean?
They identify the type of award: R01 is the standard multi-year research project grant, R21 supports exploratory work, and R03 funds small projects. Each mechanism has its own scope, duration, and page limits described on the official NIH website.
Can I apply to the NIH as an independent researcher?
Most NIH research grants are awarded to institutions, so investigators apply through a university, hospital, or eligible organization. Fellowships and some small-business programs have different rules, listed in each funding announcement.
Where do NIH applications get submitted?
Through official federal systems such as ASSIST or Grants.gov, following the specific funding opportunity announcement. Always work from the current announcement on the NIH site, not a cached or third-party copy.